BlackRock Group’s KYTHERA BIOPHARMACEUTICALS, INC COM KYTH Stock Holding History

BlackRock Group’s Portfolio KYTH Stock Details KYTH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q4	–	Sell	-5,386	Closed	-$404K	–	3122
2015 Q3	$404K	Buy	5,386 +1,206	+29%	+$90.1K	﹤0.01%	2280
2015 Q2	$315K	Buy	4,180 +2,414	+137%	+$129K	﹤0.01%	2442
2015 Q1	$89K	Buy	1,766 +624	+55%	+$26.2K	﹤0.01%	2678
2014 Q4	$40K	Buy	1,142 +182	+19%	+$6.35K	﹤0.01%	2805
2014 Q3	$31K	Buy	960 +595	+163%	+$21K	﹤0.01%	2738
2014 Q2	$14K	Sell	365 -4,061	-92%	-$142K	﹤0.01%	2789
2014 Q1	$176K	Buy	4,426 +2,033	+85%	+$90.9K	﹤0.01%	2489
2013 Q4	$89K	Buy	+2,393	New	+$99.3K	﹤0.01%	2497

BlackRock Group's KYTH Position: Q4 2015 in Review

BlackRock Group sold out of KYTHERA BIOPHARMACEUTICALS, INC COM (KYTH) in Q4 2015, closing a stake of 5,386 shares — an estimated $404K sold.

BlackRock Group first reported a position in KYTH in Q4 2013 and held it in 8 quarters. The position peaked at $404K in Q3 2015. 0 funds tracked by Wall St. Rank hold KYTH as of Q4 2015.

BlackRock Group reported no remaining KYTHERA BIOPHARMACEUTICALS, INC COM position as of Q4 2015 after selling out during the quarter.
BlackRock Group sold 5,386 KYTHERA BIOPHARMACEUTICALS, INC COM shares in Q4 2015, an estimated $404K.
BlackRock Group first reported a position in KYTHERA BIOPHARMACEUTICALS, INC COM in Q4 2013 and held it in 8 quarters.
BlackRock Group's KYTHERA BIOPHARMACEUTICALS, INC COM position peaked at $404K in Q3 2015.
0 funds tracked by Wall St. Rank held KYTHERA BIOPHARMACEUTICALS, INC COM as of Q4 2015.

Based on BlackRock Group's 13F filing for Q4 2015, filed 11 Feb 2016.